Intrapericardial therapy and diagnosis

Current Cardiology Reports

Volumn 4, Issue 1, 2002, Pages 22-25

  Spodick, David H ^a  

^a SAINT VINCENT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; HEART DISEASE; HUMAN; PARACRINE SIGNALING; PERICARDIUM; PHYSIOLOGY; REVIEW;

ANIMAL; HEART DISEASES; HUMAN; PARACRINE COMMUNICATION; PERICARDIUM;

EID: 0036134450     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-002-0122-5     Document Type: Article

References (29)

1. Spodick DH: Microphysiology of the pericardium in relation to intrapericardial therapeutics and diagnostic. Clin Cardiol 1999, 22(Suppl I):I2-I3. Describes normal pericardial microphysiology, with special reference to mesothelial production of many physiologically active substances, and the potential for stimulating their overproduction.
2. Spodick DH: Direct therapy for coronary disease, myocardial disease and severe cardiac arrhythmias. Clin Cardiol 1999, 22(Suppl I):11.
3. Seferovic PM, Ristic AD, Maksimovic R, et al.: Initial clinical experiences with Per DUCER device: promising new tool in the diagnosis and treatment of pericardial disease. Clin Cardiol 1999, 22(Suppl I):I30-I35. The first large-scale application of intrapericardial application of the PerDUCER in humans reports successes, failures, and technical problems of the learning curve.
4. Laham RJ, Simons M, Tofuji M, et al.: Modulations of myocardial perfusion and vascular reactivity by pericardial basic fibroblast growth factor: insight into ischemia-induced reduction in endothelium-dependent vasodilatation. J Thorac Cardiovas Surg 1998, 116:1022-1028.
5. Macris MP, Igo S: Minimally invasive access to the normal pericardium: initial clinical experience with a novel device. Clin Cardiol 1999, 22(Suppl I):I36-I39.
6. Ayers GM, Rho TH, Ben-David J, et al.: Amiodarone instilled into the canine pericardial sac migrates transmurally to produce electrophysiologic effects and suppress atrial fibrillation. J Cardiovasc Electrophysiol 1996, 7:713-271.
7. Chien GL, Wolff RA, David RF, van Winkle DM: "Normothermic range" temperature affects myocardial infarct size. Cardiovasc Res 1994, 28:1014-1017.
8. Waxman S, Moreno R, Rowe KA, Verrier RL: Persistent primary coronary dilation induced by transatrial delivery into the pericardial sac of nitroglycerin. J Am Coll Cardiol 1999, 33:2073-2077.
9. Verrier RL, Waxman S, Lovett EG, Moreno R: Transatrial access to normal pericardial space: a novel approach for diagnostic sampling, pericardiocentesis, and therapeutic interventions. Circulation 1998, 98:2331-2333.
10. Sosa E, Scanavacca M, D'Avila A, et al.: Endocardial and epicardial ablation guided by nonsurgical transthoracic epicardial mapping to treat recurrent ventricular tachycardia. J Cardiovasc Electrophysiol 1998, 9:229-239. Successful epicardial ablation for ventricular tachycardia that cannot be ablated endocardially.
11. Zipes DP: Targeted drug therapy. Circulation 1990, 81:1139-1141.
12. Fei L, Baron AD, Henry DP, Zipes DP: Intrapericardial delivery of L-arginine reduces the increased severity of ventricular arrhythmias during sympathetic stimulation in dogs with acute coronary occlusion: nitric oxide modulates sympathetic effects on ventricular electrophysiological properties. Circulation 1997, 96:4044-4049.
13. March KL: Methods of local gene delivery to vascular tissues. Semin Interv Cardiol 1996, 1:215-223.
14. March KL, Woody M, Mehdi K, et al.: Efficient in vivo catheterbased pericardial gene transfer mediated by adenoviral vectors. Clin Cardiol 1999, 22(Suppl I):I23-I29. Provides outstanding technical information on successful gene transfer via the intrapericardial route.
15. Uchida Y, Yanagisawa-Miwa A, Nakamura F, et al.: Angiogenic therapy of acute myocardial infarction by intrapericarial injection of basic fibroblast growth factor and heparin sulfate: an experimental study. Am Heart J 1995, 130:1182-1188.
16. Lazarous DF, Shou M, Stiber JA, et al.: Pharmacodynamics of basic fibroblast growth factor: route of administration determines myocardial and systemic distribution. Cardiovasc Res 1997, 36:78-85.
17. Landau C, Jacobs AB, Haudenschild CC: Intrapericardial basic fibroblast growth factor induces myocardial angiogenesis in a rabbit model of chronic ischemia. Am Heart J 1995, 129:924-931.
18. Hale SL, Kloner RA: Myocardial temperature reduction attenuates necrosis after prolonged ischemia in rabbits. Cardiovasc Res 1998, 40:502-507.
19. Willerson JT, Igo SR, Yao SK, et al.: Localized administration of sodium nitroprusside enhances its protection against platelet aggregation in stenosed and injured coronary arteries. Tex Heart Inst J 1996, 23:1-8.
20. Spodick DH: Physiology of the normal pericardium. In The Pericardium: a Comprehensive Textbook. Edited by Spodick DH. New York: Marcel Dekker; 1997:15-26.
21. Dusting GJ, Nolan RD: Stimulation of prostacyclin release from epicardium of anaesthetized dogs. Br J Pharmacol 1981, 74:553-562.
22. Nolan RD, Dusting GJ, Jakubowksi J, Martin TJ: The pericardium as a source of prostacyclin in the dog, ox and rat. Prostaglandins 1982, 24:887-902.
23. Kinlay S, Behrendt D, Weinstein M, et al.: Role of endothelin-1 in the active constriction of human atherosclerotic coronary arteries. Circulation 2001, 104:1114-1118.
24. Mebazaa A, Wetzel RC, Dodd-o JM, et al.: Potential paracrine role of the pericardium in the regulation of cardiac function. Cardiovasc Res 1998, 40:332-342. Basic investigations of the pericardial microphysiology in its role as a pracrine organ; well-designed and well-executed studies.
25. Corda S, Mebazaa A, Gandolfini MP, et al.: Trophic effect of human pericardial fluid on adult cardiac myocytes. Differential role of fibroblast growth factor-2 and factors related to ventricular hypertrophy. Circ Res 1997, 81:679-687.
26. Baek SH, Stoll HP, Szabo A, et al.: Pharmacokinetics of agent distribution from the pericardial space: effects of agent size and validation of a mathematical model for epicardial penetration. J Am Coll Cardiol 1998, 31:108A-109A.
27. Labhasetwar V, Underwood T, Heil RW Jr, et al.: Epicardial administration of ibutilide from polyurethane matrices: effects on defibrillation threshold and electrophysiologic parameters. J Cardiovasc Pharmacol 1994, 24:826-840.
28. Avitall B, Hare J, Zander G, et al.: Iontophoretic transmyocardial drug delivery. A novel approach to antiarrhymic therapy. Circulation 1992, 85:1582-1593.
29. Grubb SR, Cantley LK, Jones DL, Carter WH: Iatrogenic Cushing's syndrome after intrapericardial corticosteroid therapy. Ann Intern Med 1981, 95:706-707.